Alpha-1D adrenergic receptor
Details
- Name
- Alpha-1D adrenergic receptor
- Synonyms
- ADRA1A
- Alpha-1A adrenergic receptor
- Alpha-1D adrenoceptor
- Alpha-1D adrenoreceptor
- Alpha-adrenergic receptor 1a
- Gene Name
- ADRA1D
- Organism
- Humans
- Amino acid sequence
>lcl|BSEQ0019001|Alpha-1D adrenergic receptor MTFRDLLSVSFEGPRPDSSAGGSSAGGGGGSAGGAAPSEGPAVGGVPGGAGGGGGVVGAG SGEDNRSSAGEPGSAGAGGDVNGTAAVGGLVVSAQGVGVGVFLAAFILMAVAGNLLVILS VACNRHLQTVTNYFIVNLAVADLLLSATVLPFSATMEVLGFWAFGRAFCDVWAAVDVLCC TASILSLCTISVDRYVGVRHSLKYPAIMTERKAAAILALLWVVALVVSVGPLLGWKEPVP PDERFCGITEEAGYAVFSSVCSFYLPMAVIVVMYCRVYVVARSTTRSLEAGVKRERGKAS EVVLRIHCRGAATGADGAHGMRSAKGHTFRSSLSVRLLKFSREKKAAKTLAIVVGVFVLC WFPFFFVLPLGSLFPQLKPSEGVFKVIFWLGYFNSCVNPLIYPCSSREFKRAFLRLLRCQ CRRRRRRRPLWRVYGHHWRASTSGLRQDCAPSSGDAPPGAPLALTALPDPDPEPPGTPEM QAPVASRRKPPSAFREWRLLGPFRRPTTQLRAKVSSLSHKIRAGGAQRAEAACAQRSEVE AVSLGVPHEVAEGATCQAYELADYSNLRETDI
- Number of residues
- 572
- Molecular Weight
- 60462.205
- Theoretical pI
- 9.44
- GO Classification
- Functionsalpha1-adrenergic receptor activityProcessesadenylate cyclase-activating adrenergic receptor signaling pathway / adenylate cyclase-modulating G-protein coupled receptor signaling pathway / cell proliferation / cell-cell signaling / DNA metabolic process / G-protein coupled receptor signaling pathway / multicellular organismal development / negative regulation of the force of heart contraction involved in baroreceptor response to increased systemic arterial blood pressure / norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure / phospholipase C-activating G-protein coupled receptor signaling pathway / positive regulation of cell proliferation / positive regulation of cytosolic calcium ion concentration / positive regulation of smooth muscle contraction / positive regulation of vasoconstrictionComponentscytosol / integral component of plasma membrane / plasma membrane
- General Function
- Alpha1-adrenergic receptor activity
- Specific Function
- This alpha-adrenergic receptor mediates its effect through the influx of extracellular calcium.
- Pfam Domain Function
- 7tm_1 (PF00001)
- Transmembrane Regions
- 96-121 134-159 170-192 214-238 252-275 349-373 381-405
- Cellular Location
- Cell membrane
- Gene sequence
>lcl|BSEQ0019002|Alpha-1D adrenergic receptor (ADRA1D) ATGACTTTCCGCGATCTCCTGAGCGTCAGTTTCGAGGGACCCCGCCCGGACAGCAGCGCA GGGGGCTCCAGCGCGGGCGGCGGCGGGGGCAGCGCGGGCGGCGCGGCCCCCTCGGAGGGC CCGGCGGTGGGCGGCGTGCCGGGGGGCGCGGGCGGCGGCGGCGGCGTGGTGGGCGCAGGC AGCGGCGAGGACAACCGGAGCTCCGCGGGGGAGCCGGGGAGCGCGGGCGCGGGCGGCGAC GTGAATGGCACGGCGGCCGTCGGGGGACTGGTGGTGAGCGCGCAGGGCGTGGGCGTGGGC GTCTTCCTGGCAGCCTTCATCCTTATGGCCGTGGCAGGTAACCTGCTTGTCATCCTCTCA GTGGCCTGCAACCGCCACCTGCAGACCGTCACCAACTATTTCATCGTGAACCTGGCCGTG GCCGACCTGCTGCTGAGCGCCACCGTACTGCCCTTCTCGGCCACCATGGAGGTTCTGGGC TTCTGGGCCTTTGGCCGCGCCTTCTGCGACGTATGGGCCGCCGTGGACGTGCTGTGCTGC ACGGCCTCCATCCTCAGCCTCTGCACCATCTCCGTGGACCGGTACGTGGGCGTGCGCCAC TCACTCAAGTACCCAGCCATCATGACCGAGCGCAAGGCGGCCGCCATCCTGGCCCTGCTC TGGGTCGTAGCCCTGGTGGTGTCCGTAGGGCCCCTGCTGGGCTGGAAGGAGCCCGTGCCC CCTGACGAGCGCTTCTGCGGTATCACCGAGGAGGCGGGCTACGCTGTCTTCTCCTCCGTG TGCTCCTTCTACCTGCCCATGGCGGTCATCGTGGTCATGTACTGCCGCGTGTACGTGGTC GCGCGCAGCACCACGCGCAGCCTCGAGGCGGGCGTCAAGCGCGAGCGAGGCAAGGCCTCC GAGGTGGTGCTGCGCATCCACTGTCGCGGCGCGGCCACGGGCGCCGACGGGGCGCACGGC ATGCGCAGCGCCAAGGGCCACACCTTCCGCAGCTCGCTCTCCGTGCGCCTGCTCAAGTTC TCCCGTGAGAAGAAAGCGGCCAAGACTCTGGCCATCGTCGTGGGTGTCTTCGTGCTCTGC TGGTTCCCTTTCTTCTTTGTCCTGCCGCTCGGCTCCTTGTTCCCGCAGCTGAAGCCATCG GAGGGCGTCTTCAAGGTCATCTTCTGGCTCGGCTACTTCAACAGCTGCGTGAACCCGCTC ATCTACCCCTGTTCCAGCCGCGAGTTCAAGCGCGCCTTCCTCCGTCTCCTGCGCTGCCAG TGCCGTCGTCGCCGGCGCCGCCGCCCTCTCTGGCGTGTCTACGGCCACCACTGGCGGGCC TCCACCAGCGGCCTGCGCCAGGACTGCGCCCCGAGTTCGGGCGACGCGCCCCCCGGAGCG CCGCTGGCCCTCACCGCGCTCCCCGACCCCGACCCCGAACCCCCAGGCACGCCCGAGATG CAGGCTCCGGTCGCCAGCCGTCGAAAGCCACCCAGCGCCTTCCGCGAGTGGAGGCTGCTG GGGCCGTTCCGGAGACCCACGACCCAGCTGCGCGCCAAAGTCTCCAGCCTGTCGCACAAG ATCCGCGCCGGGGGCGCGCAGCGCGCAGAGGCAGCGTGCGCCCAGCGCTCAGAGGTGGAG GCTGTGTCCCTAGGCGTCCCACACGAGGTGGCCGAGGGCGCCACCTGCCAGGCCTACGAA TTGGCCGACTACAGCAACCTACGGGAGACCGATATTTAA
- Chromosome Location
- 20
- Locus
- 20p13
- External Identifiers
Resource Link UniProtKB ID P25100 UniProtKB Entry Name ADA1D_HUMAN GenBank Protein ID 177807 GenBank Gene ID M76446 GenAtlas ID ADRA1D HGNC ID HGNC:280 - General References
- Bruno JF, Whittaker J, Song JF, Berelowitz M: Molecular cloning and sequencing of a cDNA encoding a human alpha 1A adrenergic receptor. Biochem Biophys Res Commun. 1991 Sep 30;179(3):1485-90. [Article]
- Forray C, Bard JA, Wetzel JM, Chiu G, Shapiro E, Tang R, Lepor H, Hartig PR, Weinshank RL, Branchek TA, et al.: The alpha 1-adrenergic receptor that mediates smooth muscle contraction in human prostate has the pharmacological properties of the cloned human alpha 1c subtype. Mol Pharmacol. 1994 Apr;45(4):703-8. [Article]
- Schwinn DA, Johnston GI, Page SO, Mosley MJ, Wilson KH, Worman NP, Campbell S, Fidock MD, Furness LM, Parry-Smith DJ, et al.: Cloning and pharmacological characterization of human alpha-1 adrenergic receptors: sequence corrections and direct comparison with other species homologues. J Pharmacol Exp Ther. 1995 Jan;272(1):134-42. [Article]
- Weinberg DH, Trivedi P, Tan CP, Mitra S, Perkins-Barrow A, Borkowski D, Strader CD, Bayne M: Cloning, expression and characterization of human alpha adrenergic receptors alpha 1a, alpha 1b and alpha 1c. Biochem Biophys Res Commun. 1994 Jun 30;201(3):1296-304. [Article]
- Esbenshade TA, Hirasawa A, Tsujimoto G, Tanaka T, Yano J, Minneman KP, Murphy TJ: Cloning of the human alpha 1d-adrenergic receptor and inducible expression of three human subtypes in SK-N-MC cells. Mol Pharmacol. 1995 May;47(5):977-85. [Article]
- Deloukas P, Matthews LH, Ashurst J, Burton J, Gilbert JG, Jones M, Stavrides G, Almeida JP, Babbage AK, Bagguley CL, Bailey J, Barlow KF, Bates KN, Beard LM, Beare DM, Beasley OP, Bird CP, Blakey SE, Bridgeman AM, Brown AJ, Buck D, Burrill W, Butler AP, Carder C, Carter NP, Chapman JC, Clamp M, Clark G, Clark LN, Clark SY, Clee CM, Clegg S, Cobley VE, Collier RE, Connor R, Corby NR, Coulson A, Coville GJ, Deadman R, Dhami P, Dunn M, Ellington AG, Frankland JA, Fraser A, French L, Garner P, Grafham DV, Griffiths C, Griffiths MN, Gwilliam R, Hall RE, Hammond S, Harley JL, Heath PD, Ho S, Holden JL, Howden PJ, Huckle E, Hunt AR, Hunt SE, Jekosch K, Johnson CM, Johnson D, Kay MP, Kimberley AM, King A, Knights A, Laird GK, Lawlor S, Lehvaslaiho MH, Leversha M, Lloyd C, Lloyd DM, Lovell JD, Marsh VL, Martin SL, McConnachie LJ, McLay K, McMurray AA, Milne S, Mistry D, Moore MJ, Mullikin JC, Nickerson T, Oliver K, Parker A, Patel R, Pearce TA, Peck AI, Phillimore BJ, Prathalingam SR, Plumb RW, Ramsay H, Rice CM, Ross MT, Scott CE, Sehra HK, Shownkeen R, Sims S, Skuce CD, Smith ML, Soderlund C, Steward CA, Sulston JE, Swann M, Sycamore N, Taylor R, Tee L, Thomas DW, Thorpe A, Tracey A, Tromans AC, Vaudin M, Wall M, Wallis JM, Whitehead SL, Whittaker P, Willey DL, Williams L, Williams SA, Wilming L, Wray PW, Hubbard T, Durbin RM, Bentley DR, Beck S, Rogers J: The DNA sequence and comparative analysis of human chromosome 20. Nature. 2001 Dec 20-27;414(6866):865-71. [Article]
Drug Relations
- Drug Relations
DrugBank ID Name Drug group Pharmacological action? Actions Details DB00298 Dapiprazole approved yes antagonist Details DB00706 Tamsulosin approved, investigational unknown antagonist Details DB01403 Methotrimeprazine approved, investigational unknown antagonist Details DB00368 Norepinephrine approved yes agonist Details DB00590 Doxazosin approved yes antagonist Details DB01162 Terazosin approved yes antagonist Details DB00346 Alfuzosin approved, investigational yes antagonist Details DB04855 Dronedarone approved yes antagonist Details DB06144 Sertindole approved, investigational, withdrawn unknown Details DB05469 R450 investigational unknown Details DB05492 Epicept NP-1 investigational unknown Details DB06207 Silodosin approved yes antagonist Details DB06262 Droxidopa approved, investigational yes agonist Details DB06229 Ocaperidone investigational unknown Details DB00457 Prazosin approved yes antagonist Details DB00388 Phenylephrine approved yes agonist Details DB01186 Pergolide approved, investigational, vet_approved, withdrawn unknown agonist Details DB01200 Bromocriptine approved, investigational, withdrawn unknown agonist Details DB00622 Nicardipine approved, investigational unknown antagonist Details DB00321 Amitriptyline approved no antagonist Details DB00540 Nortriptyline approved no antagonist Details DB00458 Imipramine approved no antagonist Details DB00696 Ergotamine approved yes partial agonist Details DB01142 Doxepin approved, investigational unknown antagonist Details DB06694 Xylometazoline approved, investigational unknown agonist Details DB00668 Epinephrine approved, vet_approved unknown antagonist Details DB01136 Carvedilol approved, investigational unknown antagonist Details DB00575 Clonidine approved unknown agonist Details DB00800 Fenoldopam approved unknown inhibitor Details DB00248 Cabergoline approved unknown binder Details DB00211 Midodrine approved unknown agonist Details DB00723 Methoxamine approved, investigational unknown binder Details DB00925 Phenoxybenzamine approved unknown antagonist Details DB00935 Oxymetazoline approved, investigational unknown agonist Details DB09202 Cirazoline experimental yes partial agonist Details DB00692 Phentolamine approved unknown antagonist Details DB00908 Quinidine approved, investigational unknown antagonist Details DB00661 Verapamil approved unknown antagonist Details DB11124 Racepinephrine approved yes antagonist Details DB06153 Pizotifen approved unknown antagonist Details DB09128 Brexpiprazole approved, investigational unknown antagonist Details DB00598 Labetalol approved yes antagonist Details DB00934 Maprotiline approved, investigational no antagonist Details DB01224 Quetiapine approved unknown antagonist Details DB01151 Desipramine approved, investigational no antagonist Details DB00477 Chlorpromazine approved, investigational, vet_approved unknown inhibitor Details DB00370 Mirtazapine approved unknown antagonist Details DB00543 Amoxapine approved unknown antagonist Details DB06148 Mianserin approved, investigational unknown antagonist Details DB06764 Tetryzoline approved yes agonist Details DB13025 Tiapride investigational yes antagonist Details DB08922 Perospirone experimental unknown antagonist Details DB09167 Dosulepin approved yes antagonist Details DB00841 Dobutamine approved yes agonist Details DB09203 Synephrine experimental unknown Details DB09194 Etoperidone withdrawn unknown antagonist Details DB09195 Lorpiprazole approved yes antagonist Details DB09204 Arotinolol investigational yes antagonist Details DB09286 Pipamperone investigational unknown antagonist Details DB00243 Ranolazine approved, investigational no antagonist Details DB00457 Prazosin approved unknown Details DB00697 Tizanidine approved, investigational unknown agonist Details DB00433 Prochlorperazine approved, vet_approved unknown antagonist Details DB00490 Buspirone approved, investigational unknown partial agonist Details DB00715 Paroxetine approved, investigational unknown binder Details DB01175 Escitalopram approved unknown inhibitor Details DB01136 Carvedilol approved, investigational yes inhibitor Details DB00346 Alfuzosin approved, investigational yes antagonist Details DB00320 Dihydroergotamine approved, investigational unknown agonist Details DB01365 Mephentermine approved yes agonist Details DB00182 Amphetamine approved, illicit, investigational unknown agonist Details DB09205 Moxisylyte approved, investigational yes antagonist Details DB09229 Aranidipine experimental unknown agonist Details DB11577 Indigotindisulfonic acid approved, investigational no agonist Details DB13345 Dihydroergocristine approved, experimental yes antagonistagonist Details DB01049 Ergoloid mesylate approved yes antagonistagonist Details DB11273 Dihydroergocornine approved yes antagonistagonist Details DB11278 DL-Methylephedrine approved yes agonist Details DB00268 Ropinirole approved, investigational unknown antagonist Details DB01069 Promethazine approved, investigational unknown antagonist Details DB01576 Dextroamphetamine approved, illicit unknown inhibitorinducer Details